US Asthma Spacers Market Forecast to 2027 - COVID-19 Impact and Country Analysis By Product (Aerochamber, Optichamber, Volumatic, and Inspirease) and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and E-Commerce)
Market Introduction
An asthma spacer is a tube-like device attached to inhalers for better administration of doses. The spacers help the direct administration of medication into the lungs, as well as reduce the chances of side effects, which may occur if mouth and throat come in contact with the medicine. The increasing prevalence of asthma, coupled with growing adoption of asthma inhalers is projected to drive the growth of the asthma spacers market during the forecast period.
Get more information on this report : 
Market Overview and Dynamics
The US asthma spacers market is expected to reach US$ 702.27 million by 2027 from US$ 472.92 million in 2019; it is anticipated to at a CAGR of 5.3% from 2020 to 2027. Factors driving the market growth include the increasing prevalence of respiratory conditions such as asthma and chronic obstructive pulmonary disorder (COPD) and rising awareness regarding the benefits of asthma spacers. However, increased risk of adverse effects due to unlicensed prescriptions restrains the growth of the market. The COVID-19 pandemic has heavily impacted the US asthma spacers market as it has led to disrupted supply chain operations in the country. However, the healthcare authorities and government organization in the US are focusing on spreading awareness about COVID-19 among asthmatic patients as they are highly vulnerable to the infections. Such awareness programs are likely to have positive impact on the adoption of asthma spacers due to precautionary measures, which will eventually drive the market up to certain extent.
Key Market Segments
In terms of product, the aerochamber segment held the largest share of the market in 2019; also, the same segment is anticipated to register the highest CAGR in the market during the forecast period. In terms of distribution channel, the retail pharmacy segment held the largest share of the market in 2019; however, the e-commerce segment is estimated to register the highest CAGR in the market during the forecast period.
Major Sources and Companies Listed
The World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and Asthma and Allergy Foundation of America are a few of the major primary and secondary sources associated with the US asthma spacers market report.
Reasons to Buy Report
- Understand the US asthma spacers market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for the US asthma spacers market
- Efficiently plan mergers and acquisitions, and partnership deals by identifying market segments with the most promising probable sales
- Take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segments from the US asthma spacers market
- Obtain market revenue forecast for market by various segments from 2019 to 2027
US Asthma Spacers Market Segmentation
Asthma Spacers Market – By Product
Asthma Spacers Market – By Distribution Channel
- Retail Pharmacy
- Hospital Pharmacy
- E-Commerce
Company Profiles
- Cipla Inc.
- PARI GmbH
- Koninklijke Philips N.V.
- Lupin
- HAAG-STREIT GROUP
- LaboratoireProtecSom
- Monaghan Medical Corporation
- Koo Medical Equipment
- Agaplastic
- Teleflex Incorporated
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Asthma Spacers Market - By Product
1.3.2 Asthma Spacers Market - By Distribution Channel
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. ASTHMA SPACERS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 US - Pest Analysis
4.3. EXPERT OPINIONS
5. ASTHMA SPACERS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. ASTHMA SPACERS MARKET - US MARKET ANALYSIS
6.1. ASTHMA SPACERS - US MARKET OVERVIEW
6.2. ASTHMA SPACERS - US MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. ASTHMA SPACERS MARKET - REVENUE AND FORECASTS TO 2027 – PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. AEROCHAMBER
7.3.1. Overview
7.3.2. Aerochamber Market Forecast and Analysis
7.4. OPTICHAMBER
7.4.1. Overview
7.4.2. Optichamber Market Forecast and Analysis
7.5. VOLUMATIC
7.5.1. Overview
7.5.2. Volumatic Market Forecast and Analysis
7.6. INSPIREASE
7.6.1. Overview
7.6.2. Inspirease Market Forecast and Analysis
8. ASTHMA SPACERS MARKET - REVENUE AND FORECASTS TO 2027 – DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. RETAIL PHARMACY
8.3.1. Overview
8.3.2. Retail Pharmacy Market Forecast and Analysis
8.4. HOSPITAL PHARMACY
8.4.1. Overview
8.4.2. Hospital Pharmacy Market Forecast and Analysis
8.5. E-COMMERCE
8.5.1. Overview
8.5.2. E-Commerce Market Forecast and Analysis
9. IMPACT OF COVID-19 PANDEMIC ON ASTHMA SPACERS MARKET
9.1 US
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. ASTHMA SPACERS MARKET, KEY COMPANY PROFILES
11.1. CIPLA INC.
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. PARI GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. KONINKLIJKE PHILIPS N.V.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. LUPIN
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. HAAG-STREIT GROUP
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. LABORATOIREPROTECSOM
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. MONAGHAN MEDICAL CORPORATION
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. KOO MEDICAL EQUIPMENT
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. AGAPLASTIC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TELEFLEX INCORPORATED
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies - US Asthma Spacers Market
- Cipla Inc.
- PARI GmbH
- Koninklijke Philips N.V.
- Lupin
- HAAG-STREIT GROUP
- Laboratoire ProtecSom
- Monaghan Medical Corporation
- Koo Medical Equipment
- Agaplastic
- Teleflex Incorporated
- Saves and reduces time required for carrying out entry-level research by identifying the growth, size, leading players, and segments in the US asthma spacers market
- Highlights key business priorities to assist companies in order to realign their business strategies
- Highlights key findings and recommendations of crucial progressive industry trends in the US asthma spacers market, thereby allowing players across the value chain to develop effective long-term strategies
- Develops/modifies business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinizes in-depth US market trends and outlook coupled with the factors driving the market, as well as those hindering it
- Enhances the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution